Collaboration - February 9, 2021
Affibody selects Biovian as a CDMO partner for ABY-062
Affibody has selected Biovian Oy as a CDMO partner for ABY-062 recombinant protein for clinical trial use. The agreement covers the technical transfer of production processes and analytics followed by non-GMP and GMP manufacturing of the ABY-062 molecule at Biovian’s facility in Turku, Finland. Analytical method validations, aseptic fill and finish of Drug Product as […]
In a new job - September 8, 2020
Biovian appoints Head of Global Business Development
Biovian has announced that Magnus Gustafsson has been appointed Head of Global Business Development. Gustafsson will be a strong addition to the business and marketing team and will be giving his contribution to the growth acceleration of the company, it states. In his position Gustafsson will be responsible for identifying new business opportunities within both […]